Pila Pharma AB (publ) (STO:PILA)
Sweden · Delayed Price · Currency is SEK 1.740
+0.095 (5.78%)
Sep 24, 2026, 5:09 PM CET
Pila Pharma AB Market Cap
Pila Pharma AB has a market cap or net worth of 79.49 million as of September 24, 2026. Its market cap has decreased by -20.97% in one year.
Market Cap
79.49M
Enterprise Value
76.23M
Revenue
275.74K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.74
ChartMarket Cap Chart
Since July 15, 2021, Pila Pharma AB's market cap has decreased from 144.39M to 79.49M, a decrease of -44.95%. That is a compound annual growth rate of -10.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 79.49M | -8.31% |
| Dec 30, 2025 | 86.69M | -14.78% |
| Dec 30, 2024 | 101.72M | 167.21% |
| Dec 29, 2023 | 38.07M | -23.60% |
| Dec 29, 2022 | 49.83M | -54.49% |
| Dec 30, 2021 | 109.48M | -24.17% |
| Jul 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NextCell Pharma AB | 136.25M |
| Active Biotech AB | 107.95M |
| Nanologica AB | 101.92M |
| Biovica International AB | 92.24M |
| Ascelia Pharma AB | 82.79M |
| Alzinova AB | 81.46M |
| Spago Nanomedical AB | 78.08M |
| Annexin Pharmaceuticals AB | 71.30M |